Approval · Notice of Compliance 25900 · 2021
ILUMYA: Notice of Compliance 25900
Issued May 19, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25900
- Date
- May 19, 2021
- Company
- Sun Pharma Global Fze
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ILUMYA | 02516098 | Marketed |
Medicinal ingredients
- TILDRAKIZUMAB 100 MG per ML